In the light of recent media coverage about product recalls “particularly resulting from the detection and presence of NDMA” this article outlines ways to avoid the wide-ranging negative impacts on patients, pharmacies, manufacturers, pharmaceutical companies and health authorities and offers ways to mitigate the risk of future recalls.